全球数位病理学市场规模、份额、成长分析、按产品（软体、设备）、按应用（药物发现和开发、学术研究）- 2024-2031 年产业预测

Global Digital Pathology Market Size, Share, Growth Analysis, By Product(Software, device), By Application(Drug discovery & development, academic research) - Industry Forecast 2024-2031

出版日期: 2024年04月08日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022 年全球数位病理市场规模为 9.7 亿美元，预计将从 2023 年的 10.5 亿美元成长到 2031 年的 19.1 亿美元，预测期内（2024-2031 年）复合年增长率为 7.8%。

全球数位病理学市场是医疗诊断和研究行业中快速扩张的一个领域，对更精确、更有效的诊断仪器的需求不断增长，推动了全球数位病理学市场的发展。作为数位病理学的一部分，病理标本被数位化和分析，这有利于更简单的病理学家协作、更准确的诊断和更快的周转时间。对个人化医疗的需求不断增长，这需要更准确和更有针对性的诊断，这是推动数位病理学市场的主要因素之一。此外，癌症等慢性疾病发生率的上升也推动了对更有效诊断仪器的需求。由于具有提高诊断效率和准确性的潜力，人工智慧和机器学习技术在数位病理学中的使用预计也将推动市场扩张。但市场上也存在困难。数位病理设备的昂贵成本以及需要经过培训的人员来操作这些设备可能会阻碍其采用，尤其是在发展中国家。对资料安全和隐私的担忧也可能成为产业扩张的障碍。儘管存在这些障碍，该行业仍有很大的发展和创新前景。数位病理学与云端运算和远距医疗等其他技术的集成为提高效率和团队合作开闢了新的可能性。由于学术和研究机构越来越多地使用数位病理平台和远距病理会诊，市场拓展出现了新的前景。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 欧洲其他地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 拉丁美洲其他地区
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- MEA 的其余部分

竞争格局

前 5 名玩家比较
2021 年关键参与者的市场定位
主要市场参与者所采取的策略
最佳制胜策略
近期市集活动
主要公司市占率（%），2021年

主要公司简介

Philips Healthcare (Netherlands)
Leica Biosystems (Germany)
Roche Diagnostics (Switzerland)
Hamamatsu Photonics (Japan)
3DHISTECH (Hungary)
Ventana Medical Systems (US)
GE Healthcare (US)
Apollo Enterprise Imaging (US)
Olympus Corporation (Japan)
Mikroscan Technologies (US)
Inspirata (US)
PerkinElmer (US)
Huron Digital Pathology (Canada)
Sectra AB (Sweden)
PathAI (US)
Indica Labs (US)
F. Hoffmann-La Roche (Switzerland)
Nikon Corporation (Japan)
Danaher Corporation (US)
Visiopharm (Denmark)

简介目录

Product Code: SQMIG35G2172

Global Digital Pathology Market size was valued at USD 0.97 billion in 2022 and is poised to grow from USD 1.05 billion in 2023 to USD 1.91 billion by 2031, at a CAGR of 7.8% during the forecast period (2024-2031).

A rapidly expanding segment of the medical diagnostics and research industry, the worldwide digital pathology market is being propelled by the growing need for more precise and effective diagnostic instruments. Pathology specimens are digitized and analyzed as part of digital pathology, which facilitates simpler pathologist collaboration, more accurate diagnoses, and quicker turnaround times. The increasing need for individualized medicine, which necessitates more accurate and focused diagnostics, is one of the major factors propelling the digital pathology market. Furthermore, the need for more effective diagnostic instruments is being driven by the rising incidence of chronic illnesses like cancer. Due to the potential to improve diagnostic efficiency and accuracy, the use of AI and machine learning technologies in digital pathology is also anticipated to propel market expansion. But there are difficulties in the market. Adoption may be hampered by the expensive cost of digital pathology equipment and the requirement for trained individuals to run them, especially in developing nations. Concerns about data security and privacy could also be a barrier to industry expansion. Notwithstanding these obstacles, there are a lot of development and innovation prospects in the industry. Digital pathology's integration with other technologies-like cloud computing and telemedicine-opens up new possibilities for efficiency gains and teamwork. There are fresh prospects for market expansion due to the increasing use of digital pathology platforms and remote pathology consultations in academic and research institutions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Digital Pathology Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Digital Pathology Market Segmental Analysis

Global Digital Pathology Market is segmented on the basis of product, application, and region. By product, the market is segmented into software, device, and storage systems. By application, the market is segmented into drug discovery & development, academic research, and disease diagnosis. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Digital Pathology Market

The introduction of digital pathology is being propelled by ongoing developments in digital imaging technologies, including whole-slide imaging (WSI), high-resolution scanners, and image processing software. Diagnoses made with greater accuracy and efficiency are made possible by these technical advancements, which also provide better image quality, quicker scanning times, and stronger analytic tools. Artificial intelligence (AI) tools and deep learning algorithms, for instance, have made it possible to automatically analyze images and identify anomalies in pathology slides, which helps pathologists make decisions.

Restraints in the Global Digital Pathology Market

Digital pathology system implementation necessitates a large initial investment in software, storage infrastructure, and scanners. Digitizing slides, keeping up digital archives, and hiring staff can be expensive, especially for smaller labs or medical institutes with tight resources. Furthermore, several businesses may face difficulties incorporating digital pathology into their current laboratory operations and meeting the requirements for infrastructure changes and IT support.

Market Trends of the Global Digital Pathology Market

Telepathology and Remote Consultation: With the growing use of telepathology, pathologists are able to collaborate and offer professional opinions from a distance through remote diagnosis and consultation. Since telepathology reduces pathologists' exposure risk and allows for remote working, it has become more popular during the COVID-19 epidemic. For instance, pathologists can participate in interdisciplinary tumor boards, evaluate and discuss cases with colleagues virtually, or offer consults to underserved areas or regions lacking in pathology knowledge.

Artificial Intelligence and Machine Learning Integration: A noteworthy trend is the incorporation of AI and machine learning algorithms into digital pathology systems. Pathologists can benefit from AI's assistance with activities including automated tissue recognition, anomaly detection, biomarker quantification, and disease outcome prediction. With the use of these technologies, pathology diagnosis could become more effective, accurate, and repeatable. AI algorithms, for example, can assist in the automatic identification of particular features in histopathology pictures or the detection and classification of cancer cells.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Digital Pathology Market by Product

Market Overview
Software
device
and storage systems

Global Digital Pathology Market by Application

Market Overview
Drug discovery & development
academic research
and disease diagnosis

Global Digital Pathology Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Philips Healthcare (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Leica Biosystems (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Diagnostics (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hamamatsu Photonics (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
3DHISTECH (Hungary)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ventana Medical Systems (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GE Healthcare (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Apollo Enterprise Imaging (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Olympus Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mikroscan Technologies (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Inspirata (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Huron Digital Pathology (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sectra AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PathAI (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Indica Labs (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nikon Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Visiopharm (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments